- Home
- EBS vs LSAK Comparison
EBS vs LSAK Comparison
Compare EBS & LSAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBS
- LSAK
- Stock Information
- Founded
- EBS 1998
- LSAK 1997
- Country
- EBS United States
- LSAK South Africa
- Employees
- EBS N/A
- LSAK N/A
- Industry
- EBS Biotechnology: Pharmaceutical Preparations
- LSAK Investment Bankers/Brokers/Service
- Sector
- EBS Health Care
- LSAK Finance
- Exchange
- EBS Nasdaq
- LSAK Nasdaq
- Market Cap
- EBS 359.3M
- LSAK 384.3M
- IPO Year
- EBS 2006
- LSAK N/A
- Fundamental
- Price
- EBS $8.15
- LSAK $4.45
- Analyst Decision
- EBS Strong Buy
- LSAK
- Analyst Count
- EBS 3
- LSAK 0
- Target Price
- EBS $14.33
- LSAK N/A
- AVG Volume (30 Days)
- EBS 1.0M
- LSAK 41.7K
- Earning Date
- EBS 11-05-2025
- LSAK 09-10-2025
- Dividend Yield
- EBS N/A
- LSAK N/A
- EPS Growth
- EBS N/A
- LSAK N/A
- EPS
- EBS 2.53
- LSAK N/A
- Revenue
- EBS $851,600,000.00
- LSAK N/A
- Revenue This Year
- EBS N/A
- LSAK N/A
- Revenue Next Year
- EBS $19.24
- LSAK N/A
- P/E Ratio
- EBS $3.25
- LSAK N/A
- Revenue Growth
- EBS N/A
- LSAK N/A
- 52 Week Low
- EBS $4.02
- LSAK $3.39
- 52 Week High
- EBS $12.73
- LSAK $5.60
- Technical
- Relative Strength Index (RSI)
- EBS 51.40
- LSAK 44.28
- Support Level
- EBS $7.45
- LSAK $4.52
- Resistance Level
- EBS $8.62
- LSAK $4.80
- Average True Range (ATR)
- EBS 0.40
- LSAK 0.19
- MACD
- EBS -0.10
- LSAK -0.04
- Stochastic Oscillator
- EBS 38.46
- LSAK 53.93
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About LSAK Lesaka Technologies Inc.
Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates two reportable segments: Merchant and Consumer. The company operates mainly within South Africa. The Merchant segment that derives majority revenue includes activities related to the provision of goods and services provided to corporate and other juristic entities. It earns fees from processing activities performed for its customers and revenue generated from the distribution of prepaid airtime. The Consumer segment includes activities related to the provision of financial services to customers, including bank accounts, loans, and insurance products. The firm charges monthly administration fees for all bank accounts.